In partnership with Qure.ai, the hospital introduces advanced AI solutions for early lung cancer detection, promising faster diagnoses and improved survival outcomes.
Mumbai, August 27, 2025: In a milestone for Indian healthcare, Specialty Surgical Oncology (SSO) Cancer Hospital has become the first hospital in Mumbai to integrate AI-powered cancer diagnostics into its clinical workflows. Through a partnership with global health tech leader Qure.ai, the hospital is now able to detect lung nodules as small as 6mm on routine chest X-rays—enabling earlier diagnosis, quicker treatment decisions, and improved survival rates for patients.
The innovation was unveiled at the SSO Clinician Forum: AI-led Innovation in Cancer Care, where clinicians and healthcare leaders discussed how artificial intelligence is set to reshape oncology in India.
Dr. Sanket Mehta, Surgical Oncologist and Founder of SSO Cancer Hospital, said: “By bringing AI diagnostic tools into the SSO ecosystem, we are bringing world-class AI solutions into our cancer care pathways—making diagnosis faster, more accurate, and accessible. This is a critical leap forward in our journey to provide affordable and outcome-driven oncology care in India.”
The partnership with Qure.ai is designed to enhance diagnostic precision, streamline clinical workflows, and improve patient accessibility to advanced cancer care. By embedding AI in routine practices, SSO Cancer Hospital is setting a benchmark for how cutting-edge technology can be deployed to fight cancer more effectively in India.
About SSO Cancer Hospital:
SSO Cancer Hospital, founded by Dr. Sanket Mehta, is a leading specialty oncology center in Mumbai, dedicated to providing affordable, outcome-driven cancer care. The hospital focuses on advanced surgical oncology, multidisciplinary treatment approaches, and the integration of global innovations to improve patient outcomes.
